semaglutide submagna No Injection - Oral Weight Loss Treatment Semaglutide Info for Providers |
Description
Tirzepatide extends to 2036
This dual mechanism results in greater weight loss and glycemic control than GLP-1 alone (Jastreboff et al., 2022)
GLP-1 Receptor Sensitivity and Individual Variability Not everyone's GLP-1 receptors respond identically to the same medication
But theyre also not competing products
Needing only three shots a year would make it much easier for people with diabetes or obesity to stick with their drug regimens. Appel et al
